Nurocor is a leader in AI‑enabled digitalized clinical development, built on deep expertise in clinical data, metadata, and global standards. We have long championed a structured, digital‑first approach to study definition—well before initiatives such as TransCelerate’s DDF, CDISC USDM, or ICH M11 emerged. Our structured foundation is the ideal base for trustworthy, high‑quality AI and sets us apart from document‑centric solutions. The Nurocor Clinical Platform is our enterprise‑scale product suite, built on a comprehensive structured protocol model aligned with USDM out of the box. This positions us to support ICH M11 and TransCelerate CPT without re‑engineering, giving customers a ready foundation for rapid standards adoption and seamless digital data flow. In production use across multiple organizations, the platform delivers role‑based study design, structured capture of study elements, traceability, and granular access control. Its configurable applications generate accurate schedules, specimen‑management outputs, EDC‑ready specifications, synchronized documents, and integration‑ready exports—all from a single source of truth. Our structured study definition powers innovative AI features, enabling context‑aware authoring, informed design recommendations, and dependable insights grounded in clean, standards‑aligned data. Nurocor combines vision, maturity, and execution—offering a confident, future‑ready path to true digital and AI‑enabled clinical development.
If you’ve ever lost sleep over delayed study enrollment, consider 1nHealth your new weighted blanket. 1nHealth fills studies through a simple philosophy: Don’t waste the power of…
Leveraging over 30 years of experience working with large biopharma, emerging biotech, CROs, and healthcare companies, the strategic advisors, executives, and subject matter…
Block Clinical is intently focused on streamlining the myriad of logistics involved in traditional, virtual, and hybrid clinical trials. From globally integrated patient…